BSTZ BlackRock Science and Technology Term Trust - Fundamental Analysis
BEARISH
Sign in to save
Save to watchlist or track a position.
BSTZ Stock | Fundamental Analysis & Investment Insights
NYSE
Financial Services
Asset Management
Current Price
Live
$22.64
52W High
$23.47
52W Low
$15.22
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Jan 24, 2026
Market cap
$1.6B
P/E
3.64
ROE
N/A
Profit margin
N/A
Debt/Equity
N/A
Dividend yield
8.61%
AI Analysis
AI-powered fundamental assessment
Confidence
78%
BSTZ exhibits extremely weak financial health with a Piotroski F-Score of just 1/9, indicating significant fundamental deterioration. Despite a low P/E of 3.64 and an intrinsic value estimate of $43.54, the absence of key financial data—especially profitability, balance sheet metrics, and cash flow—raises serious transparency concerns. The 8.61% dividend yield appears attractive but is undermined by zero profit margins and insider selling, while technical indicators signal strong bearish momentum. Combined with no analyst coverage and negative insider sentiment, BSTZ presents high risk despite apparent valuation discount.
Key Strengths
Low P/E ratio of 3.64 suggests potential undervaluation relative to earnings
High dividend yield of 8.61% may attract income-focused investors
Payout ratio of 42.06% appears sustainable if earnings are stable
Intrinsic value estimate ($43.54) implies ~92% upside from current price of $22.64
Recent 3Y return of +76.4% indicates past capital appreciation strength
Key Risks
Piotroski F-Score of 1/9 signals severe financial distress and weak fundamentals
Zero profit, operating, and gross margins suggest no operational profitability
Critical financial data missing (ROE, ROA, debt/equity, cash flow) limits analysis and raises transparency concerns
Insider selling activity ($0.21M in sales, 0 buys) reflects lack of confidence from insiders
Technical trend score of 10/100 indicates strong bearish momentum near-term
AI Fair Value Estimate
Based on comprehensive analysis
$43.54
+92.3% above current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
44
Moderate
58
25
60
10
65
AI Verdict
High-risk investment with misleading valuation metrics due to absent fundamentals
Key drivers: Piotroski F-Score of 1/9, Missing financial health and cash flow data, Zero profitability margins, Bearish insider and technical signals
Confidence
75%
Value
58/100
Ref P/E, PEG, Graham Number
Positives
- P/E of 3.64 is significantly below sector average of 30.89
- Intrinsic value ($43.54) implies substantial discount to current price
Watchpoints
- No Graham Number available for defensive valuation benchmark
- Valuation metrics lack credibility due to missing financials
Future
25/100
Ref Growth rates
Positives
No standout positives identified.
Watchpoints
- No growth data available (YoY or Q/Q revenue/earnings growth)
- No forward P/E or PEG ratio suggests lack of earnings visibility
Past
60/100
Ref Historical trends
Positives
- 3Y price return of +76.4% shows strong historical performance
- 1Y return of +17.1% outperforms many peers
Watchpoints
- 6M and 1M returns show deceleration; 1M return is -0.8%
- 52-week high recently at $23.47, current price near resistance
Health
10/100
Ref Altman Z-Score, Piotroski F-Score
Positives
No standout positives identified.
Watchpoints
- Piotroski F-Score of 1/9 indicates critical financial weakness
- All profitability margins at 0.00%
- No Altman Z-Score, ROE, ROA, or debt/equity data available
Dividend
65/100
Ref Yield, Payout
Positives
- Dividend yield of 8.61% is high and attractive
- Payout ratio of 42.06% is moderate and potentially sustainable
Watchpoints
- Zero profit margins raise concerns about dividend coverage
- No operating cash flow data to confirm dividend sustainability
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$22.64
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for BSTZ and closest competitors.
Updated 2026-01-23
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
BSTZ
BlackRock Science and Technology Term Trust
Primary
|
+4.5% | +76.4% | +17.1% | +13.7% | -0.8% | -0.1% |
|
BMEZ
BlackRock Health Sciences Term Trust
Peer
|
-15.2% | +31.8% | +7.0% | +16.6% | +2.9% | +1.9% |
|
BITF
Bitfarms Ltd.
Peer
|
+20.7% | +142.5% | +70.2% | +122.8% | +2.6% | -7.1% |
|
BFC
Bank First Corporation
Peer
|
+120.4% | +89.8% | +41.8% | +9.5% | +7.0% | +6.0% |
|
BCAT
BlackRock Capital Allocation Term Trust
Peer
|
+28.2% | +62.6% | +16.7% | +9.3% | +5.2% | +0.9% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
3.64
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
N/A
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
$1.6B
Profitability
Profit margins and return metrics
Profit Margin
N/A
Operating Margin
N/A
Gross Margin
N/A
ROE
N/A
ROA
N/A
Growth
Revenue and earnings growth rates
Revenue Growth
N/A
Earnings Growth
N/A
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
N/A
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$N/A
Financial Services Sector Comparison
Comparing BSTZ against 208 companies in the Financial Services sector
(5 bullish, 111 neutral, 92 bearish)
P/E Ratio
3.64
This Stock
vs
30.35
Sector Avg
-88.0%
(Discount)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
BSTZ
BlackRock Science and...
|
BEARISH | $1.6B | 3.64 | -% | -% | $22.64 | |
|
BMEZ
BlackRock Health Sciences...
|
BEARISH | $1.57B | - | -% | -% | $15.54 | |
|
BITF
Bitfarms Ltd.
|
BEARISH | $1.64B | - | -12.5% | -46.4% | $2.74 | |
|
BFC
Bank First Corporation
|
NEUTRAL | $1.54B | 19.13 | 11.2% | 41.9% | $137.32 | |
|
BCAT
BlackRock Capital...
|
BEARISH | $1.54B | 9.72 | -% | -% | $14.67 |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-19 | FAIRBAIRN ROBERT WILLIAM | Director | Sale | 9,293 | $209,200 |
Insider transactions can signal confidence or concerns about company prospects
Past News Coverage
Recent headlines mentioning BSTZ from our newsroom.
Newest → oldest
No matching news yet.